Tapewire

NYSE · USD

BMY

BRISTOL MYERS SQUIBB CO

Export transactions ↓
Tapewire entity
1662
SEC CIK
0000014272
Parsed reports
2,253

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2021 Filed Mar 3, 2021 22:27 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 24,579 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000070 · wf-form4_161481041413541.xml · derivative · entry 4

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,577

Underlying: Common Stock, $0.10 par value · 24,579 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.exercise_date: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.expiration_date: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:27 UTC
Elkins David VEVP, Chief Financial Officer
Tax withholdingCommon Stock, $0.10 par value 8,573 $61.63 $528,353.99
Disclosure

SEC source: 0000014272-21-000070 · wf-form4_161481041413541.xml · nonDerivative · entry 2

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,186

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:27 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionCommon Stock, $0.10 par value 24,579 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000070 · wf-form4_161481041413541.xml · nonDerivative · entry 1

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:26 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 23,349 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000069 · wf-form4_161481038679298.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,350

Underlying: Common Stock, $0.10 par value · 23,349 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.exercise_date: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.expiration_date: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:26 UTC
Vessey RupertEVP, Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 8,944 $61.63 $551,218.72
Disclosure

SEC source: 0000014272-21-000069 · wf-form4_161481038679298.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,628

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:26 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 23,349 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000069 · wf-form4_161481038679298.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,572

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 00:28 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 3,592 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000062 · wf-form4_161283051347386.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,593

Underlying: Common Stock, $0.10 par value · 3,592 shares

Expires 2022-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 00:28 UTC
Vessey RupertEVP, Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 1,186 $61.56 $73,010.16
Disclosure

SEC source: 0000014272-21-000062 · wf-form4_161283051347386.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,223

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 00:28 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 3,592 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000062 · wf-form4_161283051347386.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:15 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000045 · wf-form4_161239772821661.xml · derivative · entry 1

Samuels Theodore R. II · CIK 0001688276 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,644.816

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:15 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000044 · wf-form4_161239771027164.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,564.742

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:16 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000046 · wf-form4_161239774719615.xml · derivative · entry 1

Rice Derica W · CIK 0001359067 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,999.564

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:16 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000047 · wf-form4_161239776424706.xml · derivative · entry 1

Paliwal Dinesh C · CIK 0001360224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,887.299

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

F3 · balance_after: The total number of derivative securities beneficially owned by the reporting person is updated to correct an administrative error in the previous Form 4.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:16 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000048 · wf-form4_161239780167999.xml · derivative · entry 1

Storch Gerald L · CIK 0001205004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,156.785

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:17 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000049 · wf-form4_161239782124115.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,424.704

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:17 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000050 · wf-form4_161239784937177.xml · derivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,174.753

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:18 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000051 · wf-form4_161239786825428.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,537.421

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:18 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000053 · wf-form4_161239790820268.xml · derivative · entry 1

Vousden Karen H · CIK 0001723884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,779.098

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:18 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000052 · wf-form4_161239788421605.xml · derivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,094.069

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:19 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000054 · wf-form4_161239792722083.xml · derivative · entry 1

YALE PHYLLIS R · CIK 0001269070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,009.784

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:19 UTC
SATO VICKI LDirector
GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000055 · wf-form4_161239794822236.xml · derivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,689.427

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:20 UTC GrantDeferred Share Units · Derivative 3,054.171 $62.21 $189,999.98
Disclosure

SEC source: 0000014272-21-000056 · wf-form4_161239796959398.xml · derivative · entry 1

Price Paula A · CIK 0001369240 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,535.414

Underlying: Common Stock, $0.10 par value · 3,054.171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:09 UTC GrantDeferred Share Units · Derivative 584.395 $62.03 $36,250.02
Disclosure

SEC source: 0000014272-21-000016 · wf-form4_160989536855328.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,260.656

Underlying: Common Stock, $0.10 par value · 584.395 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:10 UTC GrantDeferred Share Units · Derivative 564.243 $62.03 $34,999.99
Disclosure

SEC source: 0000014272-21-000017 · wf-form4_160989538863498.xml · derivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,859.843

Underlying: Common Stock, $0.10 par value · 564.243 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:10 UTC GrantDeferred Share Units · Derivative 371.997 $62.03 $23,074.97
Disclosure

SEC source: 0000014272-21-000018 · wf-form4_160989540756255.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,467.507

Underlying: Common Stock, $0.10 par value · 371.997 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:10 UTC GrantDeferred Share Units · Derivative 584.395 $62.03 $36,250.02
Disclosure

SEC source: 0000014272-21-000019 · wf-form4_160989542864904.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,187.894

Underlying: Common Stock, $0.10 par value · 584.395 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:11 UTC GrantDeferred Share Units · Derivative 523.94 $62.03 $32,500.00
Disclosure

SEC source: 0000014272-21-000020 · wf-form4_160989544623329.xml · derivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,072.75

Underlying: Common Stock, $0.10 par value · 523.94 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:11 UTC GrantDeferred Share Units · Derivative 624.698 $62.03 $38,750.02
Disclosure

SEC source: 0000014272-21-000021 · wf-form4_160989546809547.xml · derivative · entry 1

Paliwal Dinesh C · CIK 0001360224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,801.886

Underlying: Common Stock, $0.10 par value · 624.698 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:11 UTC GrantDeferred Share Units · Derivative 115.871 $62.03 $7,187.48
Disclosure

SEC source: 0000014272-21-000022 · wf-form4_160989548604314.xml · derivative · entry 1

Price Paula A · CIK 0001369240 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,469.667

Underlying: Common Stock, $0.10 par value · 115.871 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:12 UTC GrantDeferred Share Units · Derivative 463.485 $62.03 $28,749.97
Disclosure

SEC source: 0000014272-21-000023 · wf-form4_160989550304102.xml · derivative · entry 1

Rice Derica W · CIK 0001359067 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,930.189

Underlying: Common Stock, $0.10 par value · 463.485 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:12 UTC GrantDeferred Share Units · Derivative 523.94 $62.03 $32,500.00
Disclosure

SEC source: 0000014272-21-000024 · wf-form4_160989552582902.xml · derivative · entry 1

Samuels Theodore R. II · CIK 0001688276 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,421.914

Underlying: Common Stock, $0.10 par value · 523.94 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:12 UTC GrantDeferred Share Units · Derivative 564.243 $62.03 $34,999.99
Disclosure

SEC source: 0000014272-21-000025 · wf-form4_160989554313742.xml · derivative · entry 1

Storch Gerald L · CIK 0001205004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,632.914

Underlying: Common Stock, $0.10 par value · 564.243 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC GrantDeferred Share Units · Derivative 156.174 $62.03 $9,687.47
Disclosure

SEC source: 0000014272-21-000026 · wf-form4_160989556119777.xml · derivative · entry 1

Vousden Karen H · CIK 0001723884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,609.854

Underlying: Common Stock, $0.10 par value · 156.174 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC GrantDeferred Share Units · Derivative 463.485 $62.03 $28,749.97
Disclosure

SEC source: 0000014272-21-000027 · wf-form4_160989558613097.xml · derivative · entry 1

YALE PHYLLIS R · CIK 0001269070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,909.07

Underlying: Common Stock, $0.10 par value · 463.485 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
AHMED NADIMEVP and President, Hematology
Exercise / conversionRestricted Stock Units · Derivative 14,946 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000028 · wf-form4_160989560418282.xml · derivative · entry 4

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 14,946 shares

Expires 2020-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
AHMED NADIMEVP and President, Hematology
Tax withholdingCommon Stock, $0.10 par value 7,660 $62.03 $475,149.80
Disclosure

SEC source: 0000014272-21-000028 · wf-form4_160989560418282.xml · nonDerivative · entry 2

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,889

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
AHMED NADIMEVP and President, Hematology
Exercise / conversionCommon Stock, $0.10 par value 14,946 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000028 · wf-form4_160989560418282.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · EVP and President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 20,624 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000029 · wf-form4_160989562148858.xml · derivative · entry 4

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 20,624 shares

Expires 2020-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
Elkins David VEVP, Chief Financial Officer
Tax withholdingCommon Stock, $0.10 par value 11,931 $62.03 $740,079.93
Disclosure

SEC source: 0000014272-21-000029 · wf-form4_160989562148858.xml · nonDerivative · entry 2

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,180

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:13 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionCommon Stock, $0.10 par value 20,624 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000029 · wf-form4_160989562148858.xml · nonDerivative · entry 1

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:14 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 25,866 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000030 · wf-form4_160989563835134.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 25,866 shares

Expires 2020-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:14 UTC
Vessey RupertEVP, Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 13,257 $62.03 $822,331.71
Disclosure

SEC source: 0000014272-21-000030 · wf-form4_160989563835134.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,817

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:14 UTC
Vessey RupertEVP, Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 25,866 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000030 · wf-form4_160989563835134.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: In connection with the merger, all outstanding Celgene Corporation (Celgene) Performance Share Unit awards were assumed by BMS and converted into a restricted unit award. The restricted stock unit reported on this Form 4 vests in full on December 31, 2020, which is the end of the original performance period associated with the original Performance Share Unit award.

Read SEC document
December 11, 2020 Filed Feb 9, 2021 00:29 UTC
LEUNG SANDRAEVP, General Counsel
GiftCommon Stock, $0.10 par value 83,606 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000064 · wf-form5_161283055468744.xml · nonDerivative · entry 3

LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust

Disclosed balance after: 83,606

F2 · ownership.nature: Reporting person transferred shares to a Spousal Lifetime Access Trust (SLAT).

Read SEC document
December 11, 2020 Filed Feb 9, 2021 00:29 UTC
LEUNG SANDRAEVP, General Counsel
GiftCommon Stock, $0.10 par value 83,606 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000064 · wf-form5_161283055468744.xml · nonDerivative · entry 2

LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,040.333

Read SEC document
December 11, 2020 Filed Feb 9, 2021 00:29 UTC
LEUNG SANDRAEVP, General Counsel
GiftCommon Stock, $0.10 par value 4,098 $0.00 $0.00
Disclosure

SEC source: 0000014272-21-000064 · wf-form5_161283055468744.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,646.333

F1 · shares: This transaction involved a donation of securities by the Reporting Person to a charitable donor-advised fund.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:23 UTC
BOERNER CHRISTOPHER S.EVP, Chief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,637 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000296 · wf-form4_160704500612665.xml · derivative · entry 3

BOERNER CHRISTOPHER S. · CIK 0001543747 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,913

Underlying: Common Stock, $0.10 par value · 2,637 shares

Expires 2023-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:23 UTC
BOERNER CHRISTOPHER S.EVP, Chief Commercial Officer
Tax withholdingCommon Stock, $0.10 par value 1,299 $62.18 $80,771.82
Disclosure

SEC source: 0000014272-20-000296 · wf-form4_160704500612665.xml · nonDerivative · entry 2

BOERNER CHRISTOPHER S. · CIK 0001543747 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,371

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:23 UTC
BOERNER CHRISTOPHER S.EVP, Chief Commercial Officer
Exercise / conversionCommon Stock, $0.10 par value 2,637 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000296 · wf-form4_160704500612665.xml · nonDerivative · entry 1

BOERNER CHRISTOPHER S. · CIK 0001543747 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:24 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 8,792 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000297 · wf-form4_160704502687137.xml · derivative · entry 4

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,376

Underlying: Common Stock, $0.10 par value · 8,792 shares

Expires 2023-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.